<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="243">
  <stage>Registered</stage>
  <submitdate>22/08/2005</submitdate>
  <approvaldate>10/10/2005</approvaldate>
  <actrnumber>ACTRN12605000621617</actrnumber>
  <trial_identification>
    <studytitle>The effectiveness of vaginal prolapse repair employing mesh augmentation.</studytitle>
    <scientifictitle>A comparison of the effectiveness of traditional vaginal colporraphy with colporraphay using mesh augmentation in women with vaginal prolapse as assessed using the pelvic organ prolpse quantification examination.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Vaginal prolapse</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Other reproductive health and childbirth disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intervention group- Vaginal colporaphy with the use of mesh.</interventions>
    <comparator>Control group- Traditional vaginal colporaphy.</comparator>
    <control>Active</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>A reduction in the risk of prolapse recurrence without a significant increased risk of morbidity with the use of mesh over a period of 12 months.</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Absence of dysparunia</outcome>
      <timepoint>At 6 and 12 months post operatively. </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Absence of bowel symptoms</outcome>
      <timepoint>At 6 and 12 months. </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Absence of voiding problems</outcome>
      <timepoint>At 6 and 12 months.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Women with posterior and anterior vaginal wall prolapse with at least one site being of stage 2 or more.(ICS quantitative pelvic organ prolapse examination system).Women with cocomitant urinary symptoms and /or anorectal symptoms maybe included.Women requiring anterior and posterior repair.Women with urodynamic stress incontinence will be offered a mid urethral sling procedure.Willingness to participate.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Women with apical or vault prolapse of stage 2 or more(ICS quantitative pelvic organ porlapse examination system).Medically unfit for surgery.Women undergoing concomittant abdominal surgery for prolapse eg abdominal sacral colpopexy, Paravaginal repair.Refusal to participate.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Quasi randomisation</concealment>
    <sequence>The randomisatio schedule was a computer generated table of random numbers. Blocking and stratification were both used. Blocks of four were used to achieve balanced numers in the two treatment groups</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>17/02/2003</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>128</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Johnson and Johnson</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>United States of America</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Johnson and Johnson</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Commercial sector/Industry</sponsortype>
      <sponsorname>Johnson and Johnson</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Womens Hospital Melbourne</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Ann Cornish</name>
      <address>Royal Women's Hospital
132 Grattan St
Carlton VIC 3053</address>
      <phone>+61 3 93442746</phone>
      <fax />
      <email>ann.cornish@rwh.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Macus Carey</name>
      <address>Suite D 10th floor
Francis Perry House
285 Cardigan St
Carlton VIC 3053</address>
      <phone>+61 3 92215099</phone>
      <fax />
      <email>marcus.carey@affinityhealth</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>